Last $0.08 USD
Change Today -0.0065 / -7.30%
Volume 2.1M
ISCO On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by INTERNATIONAL STEM CELL CORP (ISCO) in the last 6 months

Announced 10/7/14
3.00M for International Stem Cell Corporation
Private Placement

International Stem Cell Corporation (OTCPK:ISCO) announced that it has entered into a securities purchase agreement for the private placement of 2,000 series H-1 convertible preferred shares at $1,000 per share for proceeds of $2,000,000, 500 series H-2 convertible preferred shares at $1,000 per share for gross proceeds $500,000, for aggregate gross proceeds of $2,500,000 on October 7, 2014. The company will also issue 38,800,000 series A warrants exercisable at $0.0921 ...
Read More


ISCO's price was unchanged after the transaction was announced on 10/7/14.
 
Announced 08/6/14
1.00M for International Stem Cell Corporation
Private Placement

International Stem Cell Corporation (OTCPK:ISCO) announced a private placement of 6,000,000 at a price of $0.10 per share for gross proceeds of $600,000 on August 6, 2014. The company issued shares pursuant to a securities purchase agreement to Andrey Semechkin, Co-Chairman and Chief Executive Officer of the company and Ruslan Semechkin, Chief Scientific Officer and Director of the company. The company issued 5,000,000 shares for $500,000 to Andrey Semechkin and 1,000,000 ...
Read More


ISCO's price was unchanged after the transaction was announced on 08/6/14.
 
Announced 06/26/14
1.00M for International Stem Cell Corporation
Private Placement

International Stem Cell Corporation (OTCPK:ISCO) announced a private placement of 5,500,000 shares at a price of $0.10 per share for gross proceeds of $550,000 on June 26, 2014. The transaction included participation from two accredited investors, Andrey Semechkin, Co-Chairman and Chief Executive Officer of the company and Ruslan Semechkin, Chief Scientific Officer of the company, who subscribed to 4,800,000 shares and 700,000 shares respectively. The shares are issued ...
Read More


ISCO's price was unchanged after the transaction was announced on 06/26/14.
 
Announced 05/29/14
1.00M for International Stem Cell Corporation
Private Placement

International Stem Cell Corporation (OTCPK:ISCO) announced a private placement of 3,333,333 common shares at $0.15 per share for gross proceeds of $500,000 on May 29, 2014. The transaction included participation from Andrey Semechkin, Co-Chairman and Chief Executive Officer and Dr. Ruslan Semechkin, Chief Scientific Officer and a Director. The company issued securities pursuant to exemption provided under Regulation D.


ISCO's price was unchanged after the transaction was announced on 05/29/14.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISCO:US $0.08 USD -0.0065

ISCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aastrom Biosciences Inc $2.79 USD -0.02
Bioheart Inc $0.02 USD 0.00
Cytori Therapeutics Inc $0.41 USD +0.0008
Nuo Therapeutics Inc $0.31 USD +0.005
StemCells Inc $1.16 USD -0.02
View Industry Companies
 

Industry Analysis

ISCO

Industry Average

Valuation ISCO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERNATIONAL STEM CELL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.